Prevention of chemotherapy-induced premature ovarian insufficiency in mice by scaffold-based local delivery of human embryonic stem cell-derived mesenchymal progenitor cells

BACKGROUND: Premature ovarian insufficiency (POI) is one of the most serious side effects of chemotherapy in young cancer survivors. It may not only reduce fecundity but also affect lifelong health. There is no standard therapy for preserving ovarian health after chemotherapy. Recently, administrati...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Eun-Young, Kim, Da-Seul, Lee, Min Ji, Lee, Ah Reum, Shim, Sung Han, Baek, Seung Woon, Han, Dong Keun, Lee, Dong Ryul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325282/
https://www.ncbi.nlm.nih.gov/pubmed/34332643
http://dx.doi.org/10.1186/s13287-021-02479-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325282/
https://www.ncbi.nlm.nih.gov/pubmed/34332643
http://dx.doi.org/10.1186/s13287-021-02479-3

Ejemplares similares